These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31502583)

  • 1. Deconstructing age reprogramming.
    Singh PB; Laktionov PP; Newman AG
    J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age reprogramming and epigenetic rejuvenation.
    Singh PB; Newman AG
    Epigenetics Chromatin; 2018 Dec; 11(1):73. PubMed ID: 30572909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cellular rejuvenation.
    Denoth-Lippuner A; Jessberger S
    FEBS Lett; 2019 Dec; 593(23):3381-3392. PubMed ID: 31197818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age reprogramming: cell rejuvenation by partial reprogramming.
    Singh PB; Zhakupova A
    Development; 2022 Nov; 149(22):. PubMed ID: 36383700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
    Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
    Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flaw in induced-stem-cell model.
    Dolgin E
    Nature; 2011 Feb; 470(7332):13. PubMed ID: 21293343
    [No Abstract]   [Full Text] [Related]  

  • 7. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into reprogramming to induced pluripotency.
    Ho R; Chronis C; Plath K
    J Cell Physiol; 2011 Apr; 226(4):868-78. PubMed ID: 20945378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of somatic and pluripotent cells reveals novel pathways involved in reprogramming.
    Cai YN; Dai XH; Zhang QH; Hu R; Dai ZM
    Genet Mol Res; 2015 Oct; 14(4):12085-92. PubMed ID: 26505355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
    Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
    PLoS One; ; . PubMed ID: 26938212
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.